CVA, Parkinson's, Myasthenia Gravis Flashcards
how does myasthenia gravis develop?
antibody binds to - acetylcholine receptor
blocked or destroyed
main neurotransmitter cannot bind to receptor
lack of propagation of signal from motor neuron to muscle cell
investigations for myasthenia gravis
Abs – Anti-AchR, anti-MUSK, anti-LRP4
Electrophysiology – Repetitive nerve stimulation, single fiber electromyography
Edrophonium test
Check for other autoimmune conditions – TFTs, B12
CT chest – AchR Ab +ve MG strongly associated with thymoma
triggers of myasthenia gravis
- physical exertion, infection, surgery, pregnancy, hypokalemia
- antibiotics
- CCBS
- beta blockers
- diazepam
treatment for myasthenia gravis
- acetylcholinesterase inhibitor (pyridostigmine) - first line
- prednisolone
- steroid sparing agents - azathioprine, mycophenolate mofetil
- acute deterioration - IVIG, plasma exchange
- novel monoclonal antibody treatments - rituximab, complement inhibition, anti-fc receptor antibody
myasthenia gravis mimics ______
lambert eaton myasthenic syndome
what is myasthenia gravis
autoimmune antibody mediated disease resulting in progressive weakness at the neuromuscular junction
key differences between myasthenia gravis and Lambert eaton myasthenic syndrome
- PATHOPHYSIOLOGY - MG post synaptic ach receptors, LEMS presynaptic calcium channels
- EXERTION - MG worsens, LEMS improves
- TESTING DIFFERENCES - MG dec amplitude CMAP after 2-3 Hz rep stimulation, LEMS inc amplitude CMAP after 50Hz rep stimulation
- SYMPTOMATIC THERAPY - MG acetylcholinesterase inhibitors, LEMS 3,4 diaminopyridine
- COMORBID ISSUES - MG thymoma, LEMS sclc
corticospinal tract (movement tract) path
starts at motor cortex
medulla
spinal cord
peripheral nerves to target muscles
the motor cortex direct pathway controls _______
initiation of voluntary movement
the motor cortex indirect pathway controls _______
prevention of involuntary movements
what is parkinsons disease?
neurodegenerative disease which causes a progressive decline in the neurological function and loss of neurons.
the most concentrated loss of neurons is in the ganglia.
causes of parkinsons disease
sporadic condition - normally no underlying genetic mutations, combination of environmental and common genetic factors
pathology of parkinsons disease
alpha synuclein becomes sticky and clumps forming lewy bodies in dopaminergic neurons.
these are toxic - they build up into brown neuromelanin - this specifically affects dopaminergic neurons
dopamine gradually dies away due to lewy bodies
inclusions can develop decades before motor symptom onset
pathophysiology of parkinsons disease
the amount of dopamine in the synapse is regulated
too much or too little makes smooth continuous movement difficult
Presenting symptoms of parkinsons
tremor
difficulty with fine movements
stiffness of a limb
falls
diagnostic symptoms of parkinsons
akinesia/bradykinesia
tremor
rigidity
postural instability